Skip to main content

Table 2 Distribution of EQ-5D-5L responses by dimension and age group

From: Feasibility properties of the EQ-5D-3L and 5L in the general population: evidence from the GP Patient Survey on the impact of age

Parameter

Total

Age group

Proportion in %

Dimension

Level

N

18–24

25–34

35–44

45–54

55–64

65–74

75–84

85+

Mobility

No problems

1,958,750

91.2

90.2

86.2

78.5

68.6

58.8

39.6

18.0

Slight problems

403,522

4.6

5.0

7.0

10.5

14.7

18.9

23.9

23.0

Moderate problems

268,905

1.6

1.8

2.9

5.3

8.5

12.2

20.3

29.2

Severe problems

170,235

0.6

0.8

1.6

3.4

5.7

7.3

12.1

22.0

Unable to

22,630

0.4

0.4

0.4

0.5

0.6

0.7

1.3

4.1

Self-care

No problems

2,484,621

94.9

94.7

92.9

89.6

86.2

84.3

76.6

60.2

Slight problems

149,380

1.7

1.8

2.5

3.7

5.0

6.1

9.5

15.0

Moderate problems

118,583

1.0

1.0

1.6

3.0

4.4

5.0

7.2

12.5

Severe problems

41,437

0.4

0.4

0.7

1.2

1.7

1.6

2.0

4.7

Unable to

20,059

0.4

0.4

0.4

0.4

0.5

0.5

1.2

4.3

Usual activities

No problems

1,943,526

85.3

85.4

81.8

75.0

67.7

61.4

45.3

24.6

Slight problems

446,180

7.8

7.9

9.5

12.6

15.9

19.3

24.3

24.3

Moderate problems

259,886

3.3

3.0

4.0

6.1

8.6

10.9

17.2

25.0

Severe problems

114,562

1.2

1.3

1.9

3.1

4.4

4.5

6.4

11.5

Unable to

55,120

0.6

0.6

0.8

1.1

1.5

1.7

3.9

10.9

Pain/Discomfort

No

1,272,899

72.4

68.6

60.3

49.3

40.3

33.6

24.6

18.0

Slight

874,407

18.2

20.7

24.9

29.7

33.2

33.6

34.6

31.2

Moderate

460,993

5.6

6.4

8.7

12.4

16.1

20.0

26.7

33.8

Severe

171,788

1.5

2.0

3.1

4.9

6.8

7.3

9.5

11.3

Extreme

39,224

0.4

0.6

1.0

1.6

1.8

1.4

15

2.0

Anxiety/Depression

No

1,879,193

67.0

68.6

67.5

64.5

64.5

67.3

62.0

53.6

Slight

556,159

17.3

17.7

18.4

19.4

19.4

19.0

20.7

24.1

Moderate

252,616

9.0

8.0

8.0

9.2

9.4

7.8

8.9

12.4

Severe

61,933

3.1

2.4

2.4

2.9

2.6

1.3

1.2

1.6

Extreme

30,483

1.7

1.3

1.4

1.6

1.2

0.5

0.5

0.7